Skip to main content
. 2012 Aug 15;2012(8):CD006857. doi: 10.1002/14651858.CD006857.pub2

Summary of findings 5. 10‐day cefadroxil versus 10‐day ampicillin for treating lower urinary tract infection in children.

10‐day cefadroxil versus 10‐day ampicillin for treating lower urinary tract infection in children
Patient or population: children with lower urinary tract infection
 Settings: not stated
 Intervention: 10‐day cefadroxil
 Comparison: 10‐day ampicillin
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
10‐day ampicillin 10‐day cefadroxil
Persistent bacteriuria Study population RR 0.33 
 (0.01 to 7.62) 32
 (1 study) ⊕⊝⊝⊝
 very low1,2  
62 per 1000 21 per 1000 
 (1 to 480)
Medium risk population
63 per 1000 21 per 1000 
 (1 to 480)
Persistent symptoms Study population RR 0.33 
 (0.01 to 7.62) 32
 (1 study) ⊕⊝⊝⊝
 very low1,2  
62 per 1000 21 per 1000 
 (1 to 480)
Medium risk population
63 per 1000 21 per 1000 
 (1 to 480)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Randomisation method, allocation concealment and blinding not reported.
 2 Very small numbers of patients (32) and CIs are very wide and cross 1